Junichiro Adachi Yuusuke Inaba Chisato Maki
10.2169/internalmedicine.56.7501
Intern Med
2017;56(2):187-190.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28090050/
Canagliflozin / administration & dosage Diabetes Mellitus, Type 2 / drug therapy Diabetic Ketoacidosis / diagnosis Hypoglycemic Agents / adverse effects Sodium-Glucose Transporter 2 Inhibitors
Canagliflozin / administration & dosage Diabetes Mellitus, Type 2 / drug therapy Diabetic Ketoacidosis / diagnosis Hypoglycemic Agents / adverse effects Sodium-Glucose Transporter 2 Inhibitors Case Reports Adult Canagliflozin / adverse effects Diabetic Ketoacidosis / blood Diabetic Ketoacidosis / chemically induced Diagnosis, Differential Diuresis Female Humans Hypoglycemic Agents / administration & dosage Hypoglycemic Agents Sodium-Glucose Transporter 2 Inhibitors Canagliflozin
PMC5337465
28090050
Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
2017